IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 20 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $19,816 | -60.8% | 2,935,679 | -3.4% | 0.12% | -44.5% |
| Q1 2022 | $50,573 | -63.2% | 3,037,443 | -57.8% | 0.21% | -49.3% |
| Q4 2021 | $137,477 | -52.1% | 7,201,518 | -38.2% | 0.42% | -39.7% |
| Q3 2021 | $287,285 | -40.2% | 11,649,837 | -36.9% | 0.69% | -22.7% |
| Q2 2021 | $480,088 | -23.1% | 18,450,713 | -6.5% | 0.89% | -28.0% |
| Q1 2021 | $624,546 | -12.0% | 19,726,650 | +29.0% | 1.24% | -34.3% |
| Q4 2020 | $709,819 | +172.8% | 15,297,822 | +93.6% | 1.89% | +22.4% |
| Q3 2020 | $260,177 | +123.8% | 7,903,308 | +86.6% | 1.54% | +23.4% |
| Q2 2020 | $116,258 | +337.8% | 4,235,273 | +377.4% | 1.25% | +88.8% |
| Q1 2020 | $26,558 | +16.5% | 887,179 | +7.8% | 0.66% | +15.1% |
| Q4 2019 | $22,790 | +53.7% | 823,344 | +1.0% | 0.58% | +77.5% |
| Q3 2019 | $14,829 | -25.1% | 814,796 | +0.9% | 0.32% | -35.1% |
| Q2 2019 | $19,805 | +201.2% | 807,688 | +16.8% | 0.50% | +165.4% |
| Q1 2019 | $6,576 | +2.3% | 691,494 | -4.8% | 0.19% | -28.0% |
| Q4 2018 | $6,428 | +34.5% | 726,360 | +71.0% | 0.26% | +81.2% |
| Q3 2018 | $4,779 | +204.4% | 424,820 | +246.4% | 0.14% | +148.3% |
| Q2 2018 | $1,570 | +42.7% | 122,623 | +88.4% | 0.06% | +5.5% |
| Q1 2018 | $1,100 | – | 65,096 | – | 0.06% | – |
Download | ||||||